Our Pricing

Mounjaro Horsham: Expert Weight Loss Treatment Access

Published: 3 October 2026

If you're searching for Mounjaro Horsham, Cured Pharmacy provides full access to tirzepatide weight loss injections with UK-registered prescriber assessment, transparent pricing from £124.99 and discreet delivery across West Sussex. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) leads a clinical team offering comprehensive weight management support for Horsham residents, combining the convenience of online consultation with the safety standards of a GPhC-registered pharmacy (9012511). Every prescription requires clinical assessment by a UK prescriber to ensure Mounjaro is appropriate for your individual health profile.

How to Access Mounjaro Horsham Through Cured Pharmacy

Accessing Mounjaro Horsham begins with a free online consultation that takes under three minutes to complete. Our UK-registered prescribers review your medical history, current medications, weight loss goals, and any contraindications to determine whether tirzepatide is clinically appropriate for you [1]. This assessment is mandatory for all prescription weight loss medications and ensures patient safety before dispensing.

Once approved, your Mounjaro prescription is fulfilled by our GPhC-registered pharmacy and dispatched in 100% discreet packaging with next-day delivery options available across Horsham and surrounding areas. Pricing is transparent from the outset—£124.99 for your initial supply—with no hidden consultation fees or membership charges. New patients receive £20 off their first order using code Weightlossnew, reducing the starting cost to £124.99.

Ongoing support includes dose titration guidance as you progress through the treatment schedule, side effect management advice, and prescription renewals coordinated through your patient account. Our clinical team remains available via phone (+44 116 4646009) for any questions specific to your Mounjaro treatment journey.

Why Horsham Residents Choose Cured Pharmacy for Mounjaro

Horsham patients value the combination of local accessibility and specialist weight loss expertise. Unlike high-street pharmacies with limited stock availability, our online model ensures consistent Mounjaro supply with transparent pricing that remains competitive across the UK market. The convenience of home delivery eliminates travel to physical clinics whilst maintaining full regulatory compliance through remote prescriber assessment [2].

Mounjaro Horsham Pricing and Dose Options Explained

Mounjaro Horsham pricing at Cured Pharmacy starts at £124.99 per four-week supply, with dose strength determining the exact cost. The treatment follows a structured titration schedule beginning at 2.5mg weekly for four weeks, then escalating to 5mg, 7.5mg, 10mg, 12.5mg, and finally 15mg based on tolerance and weight loss response [3]. Each dose increase occurs at four-week intervals, allowing your body to adapt and minimising gastrointestinal side effects.

Clinical trials demonstrated that higher maintenance doses (10mg-15mg) produced greater average weight reduction—up to 22.5% of initial body weight in the SURMOUNT-1 trial over 72 weeks [1]. However, prescribers individualise dosing based on efficacy, tolerability, and patient preference. Some individuals achieve their goals at lower maintenance doses, whilst others benefit from escalation to maximum strength.

Transparent pricing before consultation distinguishes our service—you know the exact cost before committing to assessment. This upfront approach contrasts with services that reveal pricing only after lengthy consultations, ensuring informed decision-making from the outset.

Clinical Efficacy of Mounjaro for Horsham Weight Loss Patients

Mounjaro Horsham patients can expect clinically significant weight loss when combined with reduced-calorie diet and increased physical activity, as demonstrated in the SURMOUNT trial programme. Participants receiving tirzepatide 15mg lost an average of 22.5% body weight compared to 2.4% with placebo over 72 weeks [1]. Even at lower maintenance doses of 10mg, average weight reduction reached 19.5%, substantially exceeding older weight loss medications [3].

Tirzepatide's dual mechanism—activating both GIP and GLP-1 receptors—produces superior appetite suppression and metabolic improvements compared to single-agonist therapies. Clinical data show reductions in HbA1c for patients with type 2 diabetes, improvements in cardiovascular risk markers including blood pressure and lipid profiles, and sustained weight loss maintenance when treatment continues [1].

Individual results vary based on adherence, baseline BMI, dietary modifications, and metabolic factors. Our prescribers set realistic expectations during consultation, emphasising that Mounjaro is a tool within a comprehensive weight management programme rather than a standalone solution.

Expected Timeline for Mounjaro Weight Loss Results

Most Horsham patients notice appetite reduction within the first week of starting Mounjaro, with measurable weight loss typically appearing by week four. The gradual dose escalation schedule means maximum efficacy develops over several months as you reach therapeutic maintenance doses. Consistent weekly injections, dietary adherence, and regular physical activity optimise outcomes throughout the treatment course [3].

Mounjaro Horsham: Managing Side Effects and Safety Considerations

The most common side effects reported with Mounjaro Horsham treatment are gastrointestinal—nausea, diarrhoea, constipation, and reduced appetite—particularly during dose escalation phases [2]. These symptoms typically diminish as your body adapts, and the gradual titration schedule specifically aims to minimise their intensity. Eating smaller, more frequent meals and avoiding high-fat foods can reduce nausea severity.

Serious but rare risks include pancreatitis, gallbladder disease, and thyroid C-cell tumours (observed in rodent studies but not confirmed in humans). Mounjaro is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [1]. Our prescribers screen for these contraindications during assessment to ensure patient safety.

Hypoglycaemia risk increases when Mounjaro is used alongside insulin or sulfonylureas, requiring dose adjustments of those medications. Patients with diabetic retinopathy should be monitored closely due to rapid glucose improvements potentially worsening the condition temporarily. All side effects should be reported to your prescriber, who can adjust dosing or provide supportive management strategies.

Comparing Mounjaro Horsham with Alternative Weight Loss Treatments

When evaluating Mounjaro Horsham against alternatives like Wegovy (semaglutide) or Saxenda (liraglutide), clinical trial data shows tirzepatide produces superior average weight loss. Head-to-head comparison in the SURPASS-2 trial demonstrated tirzepatide 15mg achieved 12.4kg average weight reduction versus 6.2kg with semaglutide 1mg over 40 weeks [3]. This dual-agonist mechanism appears more effective for appetite suppression and metabolic regulation.

However, individual response varies—some patients achieve excellent results with semaglutide at lower cost, whilst others require tirzepatide's enhanced efficacy. Saxenda requires daily injections versus weekly for Mounjaro, affecting convenience and adherence. Oral options like Wegovy tablets suit patients with needle aversion but may produce different side effect profiles.

Our prescribers discuss all suitable options during consultation, considering your medical history, previous weight loss attempts, budget, and treatment preferences. The goal is matching you with the most appropriate therapy rather than defaulting to the newest or most expensive option.

Is Mounjaro Worth the Investment for Horsham Patients?

At £124.99 monthly, Mounjaro Horsham represents a significant investment in your health. Clinical data supporting average weight loss of 15-22.5% makes it one of the most effective medical weight loss interventions available [1]. For patients with obesity-related comorbidities—type 2 diabetes, hypertension, sleep apnoea—the metabolic improvements may reduce long-term healthcare costs and improve quality of life substantially, potentially justifying the expense when other methods have failed.

Starting Your Mounjaro Horsham Treatment Journey Today

Beginning Mounjaro Horsham treatment through Cured Pharmacy requires three simple steps: complete the free online consultation, receive prescriber review within 24 hours, and have your medication dispatched in discreet packaging. The entire process from assessment to delivery typically completes within 48 hours, allowing rapid treatment initiation once approved.

Your first supply includes the 2.5mg starting dose with full injection technique instructions and dose escalation schedule. Our clinical team provides ongoing support throughout your treatment course, coordinating prescription renewals and addressing any concerns that arise. Regular weight monitoring and progress tracking help maintain motivation and allow dose optimisation based on your individual response.

Sustainable weight loss requires commitment beyond medication—incorporating dietary modifications, regular physical activity, and behavioural changes maximises Mounjaro's effectiveness. Our prescribers can recommend complementary resources including dietitian referrals and structured weight management programmes to support your long-term success. With transparent pricing, expert clinical oversight, and convenient home delivery, Cured Pharmacy makes accessing Mounjaro Horsham straightforward and affordable.

Next Steps for Horsham Patients Considering Mounjaro

If you're ready to explore whether Mounjaro suits your weight loss goals, start the free online assessment today. The consultation takes under three minutes and provides immediate clarity on eligibility, pricing, and expected timelines. Use code Weightlossnew at checkout to receive £20 off your first order, reducing your initial investment to £124.99. Our UK-registered prescribers will review your submission and contact you with their clinical decision, typically within one working day.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-218. [accessed 3 October 2026]
2. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 3 October 2026]
3. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2): A randomised, open-label, parallel-group, multicentre, phase 3 trial. The Lancet, 398(10295), 143-155. [accessed 3 October 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 3 October 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 3 October 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 3 October 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.